ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
rdf:type |
node1 |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
rdf:type |
prov:Person |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
owl:sameAs |
https://semopenalex.org/author/A5055570113 |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
foaf:familyName |
Hashimoto |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
foaf:givenName |
Junko |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |
foaf:name |
Junko Hashimoto |
ripekg:work/10.1007%2Fs13318-014-0242-5The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties |
dcterms:creator |
ripekg:author/RIPEAU4BDA912C737E7EA8Junko Hashimoto |